ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,048,762 | -9.5% | 169,849 | +2.5% | 0.00% | 0.0% |
| Q2 2023 | $3,367,113 | +111062.5% | 165,786 | -0.2% | 0.00% | 0.0% |
| Q1 2023 | $3,029 | -10.2% | 166,081 | +1.9% | 0.00% | -20.0% |
| Q4 2022 | $3,372 | -99.9% | 163,037 | +3.0% | 0.01% | -16.7% |
| Q3 2022 | $4,143,000 | +12.2% | 158,355 | +8.7% | 0.01% | +20.0% |
| Q2 2022 | $3,693,000 | +92.4% | 145,747 | +139.6% | 0.01% | +150.0% |
| Q1 2022 | $1,919,000 | -27.5% | 60,820 | -7.0% | 0.00% | -33.3% |
| Q4 2021 | $2,647,000 | +15.9% | 65,417 | -0.1% | 0.00% | 0.0% |
| Q3 2021 | $2,284,000 | +27.0% | 65,503 | -0.0% | 0.00% | +50.0% |
| Q2 2021 | $1,799,000 | +34.2% | 65,528 | +37.2% | 0.00% | 0.0% |
| Q1 2021 | $1,341,000 | +0.6% | 47,773 | -7.0% | 0.00% | 0.0% |
| Q4 2020 | $1,333,000 | +68.3% | 51,361 | +11.1% | 0.00% | +100.0% |
| Q3 2020 | $792,000 | -34.5% | 46,235 | -5.5% | 0.00% | -50.0% |
| Q2 2020 | $1,210,000 | +60.5% | 48,922 | -10.0% | 0.00% | 0.0% |
| Q1 2020 | $754,000 | +51.7% | 54,358 | +10.5% | 0.00% | +100.0% |
| Q4 2019 | $497,000 | +11.7% | 49,213 | +0.7% | 0.00% | 0.0% |
| Q3 2019 | $445,000 | +26.8% | 48,859 | +10.5% | 0.00% | 0.0% |
| Q2 2019 | $351,000 | -28.9% | 44,199 | +11.8% | 0.00% | 0.0% |
| Q1 2019 | $494,000 | +15.2% | 39,535 | -0.8% | 0.00% | 0.0% |
| Q4 2018 | $429,000 | – | 39,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |